Recordati Rare Diseases Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Recordati Rare Diseases Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11332
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥52,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥78,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Recordati Rare Diseases Inc (RRD), a subsidiary of Recordati SpA is a biopharmaceutical company that discovers and develops orphan drugs and biologics. The company’s products comprise chemet, neoprofen, panhematin, desoxyn, mustargen, carbaglu, cosmegen, peganone and tranxene, among others. It offers its products in the forms of capsules, injections and tablets. RRD’s products are used in the treatment of rare diseases such as acute intermittent porphyria, patent ductus arteriosus, Wilms’ tumor, NAGS deficiency, nonseminomatous testicular cancer, and others. The company markets its products through its distributors located across the US, Canada and others. RRD is headquartered in Lebanon, New Jersey, the US.

Recordati Rare Diseases Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Recordati Rare Diseases Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Recordati Rare Diseases Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Recordati Rare Diseases Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Recordati Rare Diseases Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Recordati Rare Diseases Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Recordati Rare Diseases Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Recordati Rare Diseases Acquires North American Rights to Cystadane 10
Partnerships 11
Prasco Labs Enters into Distribution Agreement with Recordati Rare Diseases 11
Ony Enters Into Co-Promotion Agreement With Recordati Rare Diseases For NeoProfen 12
Recordati Rare Diseases Inc – Key Competitors 13
Recordati Rare Diseases Inc – Key Employees 14
Recordati Rare Diseases Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Recordati Rare Diseases Inc, Pharmaceuticals & Healthcare, Key Facts 2
Recordati Rare Diseases Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Recordati Rare Diseases Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Recordati Rare Diseases Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Recordati Rare Diseases Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Recordati Rare Diseases Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Recordati Rare Diseases Acquires North American Rights to Cystadane 10
Prasco Labs Enters into Distribution Agreement with Recordati Rare Diseases 11
Ony Enters Into Co-Promotion Agreement With Recordati Rare Diseases For NeoProfen 12
Recordati Rare Diseases Inc, Key Competitors 13
Recordati Rare Diseases Inc, Key Employees 14

List of Figures
Recordati Rare Diseases Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Recordati Rare Diseases Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Recordati Rare Diseases Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Recordati Rare Diseases Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Recordati Rare Diseases Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Recordati Rare Diseases Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Recordati Rare Diseases Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Recordati Rare Diseases Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Recordati Rare Diseases Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bio Techne Corp (TECH)-医療機器分野:企業M&A・提携分析
    Summary Bio Techne Corp (Bio Techne), develops manufactures and sells biotechnology products and instruments for research and clinical diagnostics. The company provides proteins and antibodies, and related immunoassays and other reagents for research under brands such as R&D Systems, Novus, Biologic …
  • PT Rekayasa Industri:企業の戦略的SWOT分析
    PT Rekayasa Industri - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Medline Industries Inc-製薬・医療分野:企業M&A・提携分析
    Summary Medline Industries Inc (Medline) is one of the leading manufacturers and distributors of healthcare supplies in the US. It distributes products to diverse end users including hospitals, extended care facilities, surgery centers, home care dealers, home care agencies, commercial laundries, ph …
  • MDU Resources Group Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    MDU Resources Group Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary MDU Resources Group, Inc. (MDU) is an energy, and construction materials and services company. It mines aggregates and markets crushed stone, sand, gravel and related construction materials. The …
  • Hyundai Marine & Fire Insurance Co Ltd:企業の戦略・SWOT・財務情報
    Hyundai Marine & Fire Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hyundai Marine & Fire Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Topas Therapeutics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Topas Therapeutics GmbH (Topas Therapeutics) is a biotechnological company that designs and develops nanoparticle products loaded with antigenic peptides. The company’s pre-clinical pipeline categories are used in the treatment of allergies, immune mediated diseases, autoimmune diseases, and …
  • Nature’s One, Inc.:企業の戦略・SWOT・財務情報
    Nature’s One, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nature’s One, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Vivimed Labs Ltd (VIVIMEDLAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Vivimed Labs Ltd (Vivimed) is a supplier of niche molecules and formulations to healthcare, pharmaceuticals and specialty chemicals customers across the world. The company provides active pharmaceutical ingredients (APIs), finished dosage formulations, and specialty chemicals. It manufacture …
  • Altaba Inc.:企業のM&A・事業提携・投資動向
    Altaba Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Altaba Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Tradewinds Corporation Berhad:企業の戦略・SWOT・財務情報
    Tradewinds Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Tradewinds Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Serinus Energy Plc (SEN):石油・ガス:M&Aディール及び事業提携情報
    Summary Serinus Energy Plc (Serinus), formerly Serinus Energy Inc is an oil and gas company that explores and produces oil and natural gas products. The company explores, acquires and develops crude oil and natural gas reserves. It holds 100% interest in Satu Mare Concession located in the Eastern P …
  • Singapore Power Limited:戦略・SWOT・企業財務分析
    Singapore Power Limited - Strategy, SWOT and Corporate Finance Report Summary Singapore Power Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Oiltanking GmbH-石油・ガス分野:企業M&A・提携分析
    Summary Oiltanking GmbH (Oiltanking), a subsidiary of Marquard & Bahls AG is an independent tank storage service provider. The company offers storage facilities and associated services for oils, petroleum products, chemicals, biofuels, gases and dry bulk. It owns and operates terminals in Europe, No …
  • JEA:発電所・企業SWOT分析
    JEA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), a …
  • Lutronic Corp (085370):企業の財務・戦略的SWOT分析
    Lutronic Corp (085370) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Keio University-製薬・医療分野:企業M&A・提携分析
    Summary Keio University (Keio) is an educational institution that offers academic and research in various fields. The university provides primary and secondary education, graduate and undergraduate courses, and information technology courses. It offers academic courses in the field of economics, law …
  • Brookdale Senior Living Inc (BKD)-製薬・医療分野:企業M&A・提携分析
    Summary Brookdale Senior Living Inc (Brookdale) operates senior living communities which provide properties with high quality service, care and living accommodations for residents. The company focuses on providing an independent living, assisted living, dementia care, skilled nursing, continuing car …
  • Ekarat Engineering (Public) Co., Ltd. (AKR):企業の財務・戦略的SWOT分析
    Ekarat Engineering (Public) Co., Ltd. (AKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Intertek Group Plc (ITRK):石油・ガス:M&Aディール及び事業提携情報
    Summary Intertek Group Plc (Intertek) is a provider of quality and safety solutions to various businesses across the globe. It offers services such as testing, inspection, certification, auditing, advisory services, quality assurance, consulting, sourcing, hazardous substance testing, analytical ass …
  • Hill-Rom Holdings Inc (HRC)-医療機器分野:企業M&A・提携分析
    Summary Hill-Rom Holdings Inc (Hill-Rom) is a medical technology company that offers patient support systems, surgical solutions and other front line care products. The company’s major products and services include patient care systems; safe mobility and handling solutions; non-invasive therapeutic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆